TOKYO -- A cancer drug widely seen as a symbol of exorbitant health care costs is about to get cheaper in Japan, when the health ministry updates government-administered prescription drug prices for next fiscal year.
Economy
Japan to cut price of infamously expensive cancer drug again
Government, which already halved Opdivo price, seeks more cost relief
